Latest Capital Inflows News

Altamin Limited has completed a $1.003 million placement, bolstering its financial position to progress key projects in Italy amid ongoing permitting and partnership efforts.

Cann Group Limited has launched a comprehensive suite of option offers aimed at raising incremental capital, subject to shareholder approval at a December 23 meeting. The prospectus outlines potential dilution and financial impacts as the company seeks to strengthen its balance sheet.

GBM Resources has partially completed its $8 million placement to Wise Walkers but faces delays in receiving the remaining funds due to Chinese foreign exchange controls. Shareholder approval for the balance is now pending.

Buru Energy has issued over 55 million attaching options to shareholders who participated in its recent share purchase plan, marking a significant step in its capital raising efforts.

Minbos Resources has updated the schedule for its Placement and Share Purchase Plan, delaying the SPP opening to mid-December with completion expected by early February 2026.

Koba Resources has completed a $4.35 million placement of 87 million shares at 5 cents each, accompanied by 43.5 million free attaching options exercisable at 8 cents until mid-2028, following shareholder approval.

Aeris Resources has extended the closing date of its Share Purchase Plan to mid-December, giving shareholders more time to participate in the capital raising effort.

EQ Resources is progressing the refinancing of its €20 million Spanish debt, securing extensions on Oaktree guarantees while negotiating new financing facilities.

Buru Energy has issued 52.5 million attaching options to shareholders involved in its recent placement, following shareholder approval at the November 18 General Meeting.

Resolution Minerals has clarified its compliance with ASX disclosure rules following a $2 million placement to Tribeca Investment Partners, confirming the transaction's material impact on its share price.

Piche Resources has successfully raised approximately AUD 2 million through an oversubscribed placement, attracting strong institutional interest and issuing free attaching options to support its Argentine exploration projects.

4DMedical Limited has secured FDA clearance and immediate Medicare reimbursement for its groundbreaking CT – VQ™ lung imaging technology, accelerating commercial adoption across the US, Brazil, and Australia.